Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00502060
Recruitment Status : Completed
First Posted : July 17, 2007
Last Update Posted : May 14, 2009
Information provided by:

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2006
  Study Completion Date : June 2006